IX Biopharma issues 11,734,627 shares after warrants exercised at S$ 0.06

• IX Biopharma issued 11,734,627 new ordinary shares from warrant exercises priced at S$ 0.06 per share on July 15, 2026.
• Issued share count rose to 1,089,178,341 from 1,077,443,714.
• Warrant exercises reached 53,001,277, or 92.16% of the original warrant issue.
• Outstanding warrants total 4,508,202, each exercisable at S$ 0.06.
• Warrants expire July 17, 2026 at 5:00 p.m.; unexercised rights lapse, rendering remaining warrants invalid.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IX Biopharma Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: INCM5RBWISNLUTC7) on July 15, 2026, and is solely responsible for the information contained therein.